← FDA Drug Approvals (Drugs@FDA)

MONTELUKAST SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2012-08-03

Drug application

FDA Application #

ANDA078605

Application type

Abbreviated New Drug Application (Generic)

Brand name

MONTELUKAST SODIUM

Generic name

Montelukast Sodium

Active ingredients

MONTELUKAST SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS

First approval

2012-08-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown